NEW DELHI (Jan 17): India’s Gennova Biopharmaceuticals is working on an Omicron-specific mRNA Covid-19 vaccine candidate, it told Reuters on Monday, after a person with direct knowledge of the matter said the product could be ready in a month or two.
“The Omicron-specific variant of the vaccine is under development and will be ready for human clinical trials, subject to regulatory approvals,” a company spokesperson said in a text message. “We will keep you posted.”
The source, who did not want to be named as the information was private, said the product might need a small trial in India before it could be rolled out.
Pfizer Inc said last week a redesigned Covid-19 vaccine that specifically targets the Omicron coronavirus variant could be ready to launch by March.
Gennova said that on Friday it submitted to India’s drug regulator phase-two trial data for its original mRNA vaccine candidate. The government said last year that product was found to be “safe, tolerable, and immunogenic” in the participants of an initial study.
If given emergency-use approval, this would be the country’s first mRNA Covid-19 vaccine like the ones developed by Pfizer and Moderna.
- North Korea's Kim orders military to stabilise supply of COVID-19 drugs
- Skin lesions, hearing loss: Four strange Covid-19 symptoms you might not have heard about
- New daily Covid-19 infections drop to a three-month low
- Kim Jong Un slams North Korean officials over COVID-19 response
- Pyongyang turns to Beijing for Covid help: sources
- North Korea mobilises military as suspected COVID outbreak surges
- Readymade garment exporters want India to ban cotton exports
- North Korea bring in the military to distribute COVID drugs as country battles outbreak
- How bad could Omicron get in North Korea?
- ASEAN aims to develop global vaccine passport
- Yoon Suk-yeol tells Assembly bipartisanship is needed
- Rebel Foods to deploy TagBox's real-time cold chain monitoring system
- Roche Pharma launches drug to treat breast cancer
- FDCI X Lakme Fashion Week returns to Mumbai, to be held from October 12
- Prudent to estimate GDP growth at 7.8-8 per cent at present oil price levels: CII President
- Samsung Galaxy Z Fold 4's cameras to be better than Galaxy S22 Ultra, reveals new leak
- SBI increases MCLR on loans: Check latest interest rates here
- PM Modi holds bilateral talks with his Nepalese counterpart Sher Bahadur Deuba in Lumbini
- Pakistan: Maryam Nawaz dares Imran Khan to show proof of "assassination plot"
- Hemorrhaging, abdominal pain: 6 warning signs of severe dengue
India's Gennova developing Omicron-specific Covid-19 vaccine have 392 words, post on www.theedgemarkets.com at January 17, 2022. This is cached page on Business News. If you want remove this page, please contact us.